To further clarify the role of lncRNA CBR3-AS1 across various cancers, a meta-analysis was conducted to assess the impact of its aberrant expression on the prognostic significance and clinicopathological characteristics of cancer patients. This evidence concerns the gene CBR3 and cancer.